Search Results - "Kirchhof, G"

Refine Results
  1. 1

    Glycemic Control in the Treatment of Psoriasis by Ip, Wilfred, Kirchhof, Mark G

    Published in Dermatology (Basel) (01-01-2017)
    “…Psoriasis is a common chronic inflammatory skin disease that manifests as scaly erythematous plaques as a consequence of keratinocyte hyperproliferation and…”
    Get more information
    Journal Article
  2. 2

    A molecular perspective of CTLA-4 function by Teft, Wendy A, Kirchhof, Mark G, Madrenas, Joaquín

    Published in Annual Review of Immunology (01-01-2006)
    “…Within the paradigm of the two-signal model of lymphocyte activation, the interest in costimulation has witnessed a remarkable emergence in the past few years…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Retrospective review of Stevens-Johnson syndrome/toxic epidermal necrolysis treatment comparing intravenous immunoglobulin with cyclosporine by Kirchhof, Mark G., MD, PhD, Miliszewski, Monica A., MD, Sikora, Sheena, MD, Papp, Anthony, MD, PhD, Dutz, Jan P., MD

    “…Background Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are mucocutaneous reactions, typically to medications, that are associated with…”
    Get full text
    Journal Article
  5. 5

    Infection risk of dermatologic therapeutics during the COVID‐19 pandemic: an evidence‐based recalibration by Ghazawi, Feras M., Lim, Megan, Dutz, Jan P., Kirchhof, Mark G.

    Published in International journal of dermatology (01-09-2020)
    “…Recommendations were made recently to limit or stop the use of oral and systemic immunotherapies for skin diseases due to potential risks to the patients…”
    Get full text
    Journal Article
  6. 6

    YouTube as a source of misinformation on COVID-19 vaccination: a systematic analysis by Li, Heidi Oi-Yee, Pastukhova, Elena, Brandts-Longtin, Olivier, Tan, Marcus G, Kirchhof, Mark G

    Published in BMJ global health (01-03-2022)
    “…IntroductionVaccines for SARS-CoV-2 have been accessible to the public since December 2020. However, only 58.3% of Americans are fully vaccinated as of 5…”
    Get full text
    Journal Article
  7. 7

    Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: An Analysis of Triggers and Implications for Improving Prevention by Miliszewski, Monica A., MD, Kirchhof, Mark G., MD, PhD, Sikora, Sheena, MD, Papp, Anthony, MD, Dutz, Jan P., MD

    Published in The American journal of medicine (01-11-2016)
    “…Abstract Background Stevens-Johnson syndrome and toxic epidermal necrolysis are severe mucocutaneous adverse drug reactions characterized by extensive…”
    Get full text
    Journal Article
  8. 8
  9. 9

    A case of drug-induced bullous pemphigoid secondary to immunotherapy treated with upadacitinib: A case report by Gresham, Louise M, Kirchhof, Mark G

    Published in SAGE open medical case reports (01-01-2023)
    “…Bullous pemphigoid is an acquired autoimmune subepidermal blistering disease that can arise following exposure to systemic medication, referred to as…”
    Get full text
    Journal Article
  10. 10

    Stomatin-Like Protein 2 Binds Cardiolipin and Regulates Mitochondrial Biogenesis and Function by Christie, Darah A., Lemke, Caitlin D., Elias, Isaac M., Chau, Luan A., Kirchhof, Mark G., Li, Bo, Ball, Eric H., Dunn, Stanley D., Hatch, Grant M., Madrenas, Joaquín

    Published in Molecular and Cellular Biology (01-09-2011)
    “…Article Usage Stats Services MCB Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
    Get full text
    Journal Article
  11. 11

    Pyoderma gangrenosum treated with secukinumab: A case report by McPhie, Meghan L, Kirchhof, Mark G

    Published in SAGE open medical case reports (01-07-2020)
    “…Pyoderma gangrenosum is a challenging disease to manage, due in part to the lack of approved treatment therapies. Recently, the emergence of biologic agents…”
    Get full text
    Journal Article
  12. 12

    Treatment of renal pruritus with dupilumab monotherapy: A case report by Glockler-Lauf, S. Dresden, Kirchhof, Mark G

    Published in SAGE open medical case reports (01-01-2024)
    “…Chronic kidney disease-associated pruritus leads to decreased quality of life and is an independent risk factor for mortality. There is limited evidence for…”
    Get full text
    Journal Article
  13. 13

    Root zone temperature alters storage root formation and growth of sweetpotato by Taranet, P., Kirchhof, G., Fujinuma, R., Menzies, N.

    “…Large mounds amended with plant residues are a common cultivation method for sweetpotato (Ipomoea batatas) in the western parts of the Papua New Guinea…”
    Get full text
    Journal Article
  14. 14

    Practical Recommendations on Laboratory Monitoring in Patients with Atopic Dermatitis on Oral JAK Inhibitors by Kirchhof, Mark G., Prajapati, Vimal H., Gooderham, Melinda, Hong, Chih-ho, Lynde, Charles W., Maari, Catherine, Turchin, Irina, Papp, Kim A.

    Published in Dermatology and therapy (01-09-2024)
    “…Oral Janus kinase inhibitors (JAKi), a class of advanced targeted systemic therapy, have demonstrated efficacy and safety in the treatment of…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Tattoos and human papilloma virus: A case report of tattoo-associated flat warts (verrucae planae) by Kirchhof, Mark G, Wong, Se Mang

    Published in SAGE open medical case reports (01-06-2019)
    “…The prevalence of tattoos is increasing and as such every physician must be aware of the potential adverse events associated with tattooing. Here we present a…”
    Get full text
    Journal Article
  17. 17

    Microarray analysis of RpoS-mediated gene expression in Escherichia coli K-12 by Patten, C L, Kirchhof, M G, Schertzberg, M R, Morton, R A, Schellhorn, H E

    Published in Molecular genetics and genomics : MGG (01-12-2004)
    “…The alternative sigma factor RpoS controls the expression of many stationary-phase genes in Escherichia coli and other bacteria. Though the RpoS regulon is a…”
    Get full text
    Journal Article
  18. 18

    Novel Kappa-Opioid Receptor Agonist for the Treatment of Cholestatic Pruritus: Systematic Review by Bailey, Adrian Joseph Michel, Li, Heidi Oi-Yee, Kirchhof, Mark G

    Published in JMIR dermatology (02-05-2022)
    “…[...]the impact of chronic pruritis is thought to be comparable to that of chronic pain. There has been emerging evidence from various clinical trials…”
    Get full text
    Journal Article
  19. 19

    RpoS regulation of gene expression during exponential growth of Escherichia coli K12 by Dong, Tao, Kirchhof, Mark G., Schellhorn, Herb E.

    Published in Molecular genetics and genomics : MGG (01-03-2008)
    “…RpoS is a major regulator of genes required for adaptation to stationary phase in E. coli . However, the exponential phase expression of some genes is affected…”
    Get full text
    Journal Article
  20. 20

    Mitochondrial and plasma membrane pools of stomatin-like protein 2 coalesce at the immunological synapse during T cell activation by Christie, Darah A, Kirchhof, Mark G, Vardhana, Santosh, Dustin, Michael L, Madrenas, Joaquín

    Published in PloS one (18-05-2012)
    “…Stomatin-like protein 2 (SLP-2) is a member of the stomatin-prohibitin-flotillin-HflC/K (SPFH) superfamily. Recent evidence indicates that SLP-2 is involved in…”
    Get full text
    Journal Article